Q2N0S6 (Q2N0S6_9HIV1) Human immunodeficiency virus 1

Envelope glycoprotein gp160 UniProtKBInterProInteractive Modelling

860 aa; Sequence (Fasta)

Available Structures

159 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Cytoplasmic tail deleted HIV-1 Env bound with three 4E10 Fabs
7sd3
 Heteromer
30-681
6×NAG; 3×NAG; 36×NAG;
Assess
Cytoplasmic tail deleted HIV Env trimer in nanodisc
7sc5
 Heteromer
30-668
6×NAG; 3×NAG; 36×NAG;
Assess
Crystal Structure at 3.7 A Resolution of Fully Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion…
5fyl
 Heteromer
30-661
6×NAG; 9×NAG; 3×NAG; 3×NAG; 9×NAG; 12×NAG; 6×NAG; 3×NAG; 3×NAG; 12×NAG;
Assess
3.5 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trime…
5t3z
 Heteromer
30-661
3×NAG; 6×NAG; 12×NAG; 3×NAG; 6×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 6×NAG;
Assess
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting A…
5i8h
 Heteromer
30-661
3×NAG; 3×NAG; 21×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 24×NAG;
Assess
Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT12…
5c7k
 Heteromer
P01834; P01857; S6B291; 		30-661
12×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4;
Assess
Cryo-EM structure of M4008_N1 Fab in complex with BG505 DS-SOSIP.664 Env trimer
7rai
 Heteromer
30-661
3×NAG; 15×NAG; 15×NAG; 3×NAG; 21×NAG;
Assess
Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP an…
6nf2
 Heteromer
30-661
15×NAG; 9×NAG; 6×NAG; 12×NAG; 3×NAG; 3×NAG; 9×NAG;
Assess
BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R
6vkn
 Heteromer
30-661
18×NAG; 3×NAG; 3×NAG; 39×NAG;
Assess
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074
6orn
 Heteromer
30-661
4×NAG; 3×NAG; 2×NAG; 12×NAG; 30×NAG;
Assess
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab87…
6oro
 Heteromer
30-661
3×NAG; 3×NAG; 3×NAG; 18×NAG; 21×NAG;
Assess
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-2 from animal Rh.33311 (Wk26 tim…
7l8u
 Heteromer
30-661
9×NAG; 2×NAG; 1×NAG; 47×NAG;
Assess
Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 3)
8g9y
 Heteromer
30-661
21×NAG; 12×NAG; 3×NAG; 3×NAG; 15×NAG;
Assess
Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 1)
8g9w
 Heteromer
30-661
21×NAG; 12×NAG; 3×NAG; 3×NAG; 15×NAG;
Assess
Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV…
6n1v
 Heteromer
30-661
21×NAG; 6×NAG; 6×NAG; 9×NAG; 9×NAG;
Assess
Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 2)
8g9x
 Heteromer
30-661
24×NAG; 12×NAG; 3×NAG; 15×NAG;
Assess
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
8sw7
 Heteromer
30-661
3×NAG; 49×NAG;
Assess
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-1 from animal Rh.33311 (Wk26 tim…
7l8t
 Heteromer
30-661
9×NAG; 1×NAG; 2×NAG; 54×NAG;
Assess
Cryo-EM structure of vaccine-elicited antibody 0PV-a.01 in complex with HIV-1 Env BG505 DS-SOSIP an…
6osy
 Heteromer
30-661
12×NAG; 18×NAG; 6×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG;
Assess
Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP an…
6ot1
 Heteromer
30-661
21×NAG; 9×NAG; 9×NAG; 3×NAG; 3×NAG; 12×NAG;
Assess
The CryoEM structure of N49-P9.6-FR3 and PGT121 Fabs in complex with BG505 SOSIP.664
7uoj
 Heteromer
30-661
21×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 15×NAG;
Assess
Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 En…
6cuf
 Heteromer
30-661
9×NAG; 9×NAG; 15×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG;
Assess
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab27…
6orq
 Heteromer
30-661
16×NAG; 2×NAG; 4×NAG; 29×NAG;
Assess
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab89…
6orp
 Heteromer
30-661
16×NAG; 10×NAG; 2×NAG; 1×NAG; 22×NAG;
Assess
Cryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complex
5thr
 Heteromer
P01730; 		30-661
3×NAG; 6×NAG;
Assess
Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env T…
5v7j
 Heteromer
31-661
6×NAG; 12×NAG; 6×NAG; 6×NAG; 3×NAG; 6×NAG; 9×NAG;
Assess
Crystal structure of BG505-SOSIP.v4.1-GT1-N137A in complex with Fabs 35022 and 9H/109L
5w6d
 Heteromer
31-661
3×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 12×NAG;
Assess
Crystal structure of the cleavage-independent prefusion HIV Env glycoprotein trimer of the clade A …
6b0n
 Heteromer
31-661
3×NAG; 6×NAG; 9×NAG; 6×NAG; 9×NAG; 3×NAG; 3×MAN; 3×BMA; 36×NAG; 6×MAN;
Assess
Structure of the BG505 SOSIP.664 trimer in complex with neutralizing antibody Fab fragments 10-1074…
7ucf
 Heteromer
31-661
1×NAG; 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 2×MAN; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 3×NAG; 1×FUC;
Assess
HIV gp140 trimer MD39-10MUTA in complex with Fabs PGT124 and 35022
5t3s
 Heteromer
31-661
6×NAG; 12×NAG; 3×NAG; 6×NAG; 3×NAG; 21×NAG;
Assess
HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-4…
5wdu
 Heteromer
31-661
9×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 33×NAG;
Assess
Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-MM28 FAB
8euw
 Heteromer
30-660
18×NAG; 3×NAG; 3×NAG; 21×NAG;
Assess
HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074
6udk
 Heteromer
Q6PJF2; Q8N355; S6B2B6; S6C4S0; 		30-660
7×NAG; 3×NAG; 2×NAG; 2×NAG; 1×NAG; 27×NAG;
Assess
BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145
5v8l
 Heteromer
31-661
28×NAG; 5×NAG; 1×NAG; 3×NAG; 3×NAG; 3×NAG; 20×NAG;
Assess
Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01 FAB
8euu
 Heteromer
30-660
24×NAG; 3×NAG; 3×NAG; 15×NAG;
Assess
Structure of Bispecific CAP256V2LS-J3 Fab in complex with BG505 DS-SOSIP.664
8fis
 Heteromer
31-661
8×NAG; 22×NAG; 6×NAG; 5×NAG; 25×NAG;
Assess
BG505 SOSIP.v5.2 in complex with rabbit Fab 43A2
6vo0
 Heteromer
30-660
18×NAG; 3×NAG; 27×NAG;
Assess
Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-COMBO1 FAB
8euv
 Heteromer
30-660
24×NAG; 3×NAG; 3×NAG; 15×NAG;
Assess
HIV-1 Env (BG505 SOSIP.664) in complex with the IgA bNAb 7-269 and the antibody 3BNC117.
7pc2
 Heteromer
31-661
19×NAG; 3×NAG; 5×NAG; 10×NAG; 3×NAG; 1×NAG; 3×NAG; 20×NAG;
Assess
Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664
6xrt
 Heteromer
31-661
10×NAG; 4×NAG; 1×NAG; 2×NAG; 1×NAG; 40×NAG;
Assess
BG505 SOSIP.664 Trimer
6v0r
 Heteromer
30-660
12×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 33×NAG;
Assess
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-8 from animal Rh.33311 (Wk26 tim…
7l90
 Heteromer
30-660
7×NAG; 3×NAG; 52×NAG;
Assess
Cryo-EM structure of llama J3 VHH antibody in complex with HIV-1 Env BG505 DS-SOSIP.664
7lpn
 Heteromer
31-661
6×NAG; 15×NAG; 6×NAG; 33×NAG;
Assess
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-7 from animal Rh.33311 (Wk26 tim…
7l8z
 Heteromer
30-660
18×NAG; 2×NAG; 1×NAG; 1×NAG; 39×NAG;
Assess
BG505 SOSIP.v5.2 in complex with VRC40.01 and RM19R Fabs
7lg6
 Heteromer
30-660
30×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG;
Assess
BG505.MD39TS Env trimer in complex with Fab from antibody C05
7sq1
 Heteromer
31-661
21×NAG; 1×BMA; 3×NAG; 1×NAG; 41×NAG;
Assess
BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117
5v8m
 Heteromer
31-661
3×NAG; 24×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG;
Assess
Cryo-EM Structure of PG9RSH DU025 Fab in complex with BG505 DS-SOSIP.664
8fl1
 Heteromer
31-661
17×NAG; 2×NAG; 3×NAG; 1×NAG; 40×NAG;
Assess
BJOX2000.664 trimer in complex with Fab fragment of broadly neutralizing HIV antibody PGT145
8jtd
 Heteromer
31-661
25×NAG; 5×NAG; 1×NAG; 3×NAG; 2×NAG; 1×NAG; 20×NAG;
Assess
CNE55.664 trimer in complex with broadly neutralizing HIV antibody PGT145
8jtm
 Heteromer
31-661
25×NAG; 5×NAG; 1×NAG; 3×NAG; 2×NAG; 1×NAG; 20×NAG;
Assess
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry…
6mtj
 Heteromer
31-660
3×NAG; 6×NAG; 9×NAG; 3×NAG; 36×NAG; 3×83G;
Assess
Crystal Structure of HIV-1 BG505 DS-SOSIP.3mut Prefusion Env Trimer in Complex with Human Antibodie…
6w03
 Heteromer
31-660
6×NAG; 15×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG;
Assess
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry…
6mtn
 Heteromer
31-660
4×NAG; 1×NAG; 2×NAG; 1×NAG; 11×NAG; 1×JYJ;
Assess
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry…
6mu7
 Heteromer
31-660
3×NAG; 6×NAG; 9×NAG; 3×NAG; 36×NAG; 3×JYY;
Assess
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry…
6mu6
 Heteromer
31-660
3×NAG; 6×NAG; 12×NAG; 3×NAG; 30×NAG; 3×JYV;
Assess
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with …
6nnj
 Heteromer
31-660
3×NAG; 15×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG;
Assess
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex …
6nm6
 Heteromer
31-660
3×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG;
Assess
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to VRC01 FR3-03 scFv in Compl…
6nnf
 Heteromer
31-660
3×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 15×NAG;
Assess
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry…
6mu8
 Heteromer
31-660
3×NAG; 6×NAG; 9×NAG; 3×NAG; 33×NAG; 3×JYS;
Assess
Crystal structure of 8ANC195 Fab in complex with BG505 SOSIP.664 HIV-1 Env trimer
5cjx
 Heteromer
32-661
2×NAG; 5×NAG; 3×NAG; 2×NAG; 2×NAG; 2×NAG; 6×NAG;
Assess
3.9 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trime…
5t3x
 Heteromer
32-661
3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG;
Assess
Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizin…
5d9q
 Heteromer
S6B291; 		31-660
9×NAG; 3×NAG; 18×NAG; 6×NAG; 3×NAG; 3×NAG; 18×NAG;
Assess
Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and …
8d0y
 Heteromer
31-660
6×NAG; 6×NAG; 3×NAG; 12×NAG; 3×NAG; 18×NAG;
Assess
Crystal structure of the BG505 triple tandem trimer gp140 HIV-1 Env in complex with PGT124 and 35O22
8tgo
 Heteromer
31-660
1×NAG; 14×NAG; 6×NAG; 3×NAG; 2×NAG; 31×NAG;
Assess
Uncleaved prefusion optimized gp140 trimer with an engineered 10-residue HR1 turn bound to broadly …
5jsa
 Heteromer
32-661
9×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 15×NAG; 3×NAG; 3×NAG; 6×NAG;
Assess
Uncleaved prefusion optimized gp140 trimer with an engineered 8-residue HR1 turn bound to broadly n…
5js9
 Heteromer
32-661
12×NAG; 6×NAG; 3×NAG; 6×NAG; 9×NAG; 3×NAG; 3×NAG; 12×NAG;
Assess
Cryo-EM Structure of PG9RSH DU011 Fab in complex with BG505 DS-SOSIP.664
8fk5
 Heteromer
A4F255; Q6PJG0; 		32-661
16×NAG; 3×NAG; 3×NAG; 1×NAG; 38×NAG;
Assess
BG505 SOSIP.v5.2(7S) in complex with the monoclonal antibodies Rh.33172 mAb.1 and RM19R
7mep
 Heteromer
32-661
3×NAG; 12×NAG; 51×NAG;
Assess
Cryo-EM structure of VRC01.23 in complex with HIV-1 Env BG505 DS.SOSIP
6vi0
 Heteromer
32-661
9×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 36×NAG;
Assess
BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP42 fragmentantigen binding …
6nfc
 Heteromer
32-661
15×NAG; 3×NAG; 39×NAG;
Assess
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.32034 (Wk26 time point)
7l87
 Heteromer
32-661
33×NAG; 1×NAG; 3×NAG; 2×NAG; 13×NAG;
Assess
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.33104 (Wk26 time point)
7l8b
 Heteromer
32-661
25×NAG; 3×NAG; 29×NAG;
Assess
BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component B)
7l7u
 Heteromer
32-661
3×NAG; 21×NAG; 39×NAG;
Assess
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.32034 (Wk26 time point)
7l88
 Heteromer
32-661
26×NAG; 2×NAG; 1×NAG; 27×NAG;
Assess
BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP1 fragmentantigen binding a…
6nf5
 Heteromer
32-661
15×NAG; 3×NAG; 3×NAG; 33×NAG;
Assess
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.32034 (Wk26 time point)
7l89
 Heteromer
32-661
34×NAG; 3×NAG; 17×NAG;
Assess
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-4 from animal Rh.33311 (Wk26 tim…
7l8x
 Heteromer
32-661
20×NAG; 1×NAG; 2×NAG; 42×NAG;
Assess
BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195
5vj6
 Heteromer
P0DOX5; Q6GMW3; Q8TCD0; S6B291; 		32-661
Assess
Cryo-EM structure of HIV-1 Env(BG505.T332N SOSIP) in complex with DH1030.1 Fab
8dp1
 Heteromer
31-660
3×NAG; 5×NAG; 6×NAG; 1×NAG; 33×NAG;
Assess
BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3
7mdu
 Heteromer
32-661
8×NAG; 1×NAG; 12×NAG;
Assess
BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component A)
7l7t
 Heteromer
32-661
3×NAG; 24×NAG; 39×NAG;
Assess
Cryo-EM Structure of PGT145 DU303 Fab in complex with BG505 DS-SOSIP.664
8flw
 Heteromer
32-661
14×NAG; 4×NAG; 5×NAG; 35×NAG;
Assess
BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time poin…
7l8e
 Heteromer
32-661
3×NAG; 18×NAG; 44×NAG;
Assess
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.32034 (Wk26 time point)
7l86
 Heteromer
32-661
30×NAG; 3×NAG; 24×NAG;
Assess
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.33104 (Wk26 time point)
7l8c
 Heteromer
32-661
36×NAG; 2×NAG; 4×NAG; 17×NAG;
Assess
Cryo-EM structure of PGT128 Fab in complex with BG505 SOSIP.664 Env trimer
5aco
 Heteromer
32-661
18×NAG; 21×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG;
Assess
BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195
5viy
 Heteromer
P01834; Q8TCD0; S6B291; 		32-661
10×NAG; 18×NAG; 5×NAG; 3×NAG; 7×NAG; 1×NAG; 13×NAG;
Assess
Initial contact of HIV-1 Env with CD4: Cryo-EM structure of BG505 DS-SOSIP trimer in complex with C…
5u1f
 Heteromer
P01730; 		32-661
Assess
Crystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations …
5utf
 Heteromer
30-658
6×NAG; 3×NAG; 27×NAG; 3×NAG; 3×NAG; 21×NAG;
Assess
Crystal structure of broadly neutralizing antibody N49P6 Fab in complex with HIV-1 BG505 SOSIP.664 …
6oz4
 Heteromer
33-661
9×NAG; 21×NAG; 3×NAG; 3×NAG; 21×NAG;
Assess
Crystal structure of bovine Fab NC-Cow1 in complex with HIV-1 BG505 SOSIP.664, and human Fabs 35022…
6opa
 Heteromer
31-659
3×NAG; 6×NAG; 9×NAG; 9×NAG; 12×NAG; 6×NAG;
Assess
vFP52.02 Fab in complex with BG505 DS-SOSIP Env trimer
8g85
 Heteromer
31-659
3×NAG; 12×NAG; 2×NAG; 4×NAG; 35×NAG;
Assess
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.33104 (Wk26 time point)
7l8d
 Heteromer
33-661
31×NAG; 3×NAG; 1×NAG; 20×NAG;
Assess
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-3 from animal Rh.33311 (Wk26 tim…
7l8w
 Heteromer
32-660
1×NAG; 5×NAG; 2×NAG; 57×NAG;
Assess
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-5 from animal Rh.33311 (Wk26 tim…
7l8y
 Heteromer
32-660
10×NAG; 3×NAG; 45×NAG;
Assess
Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab
7mxe
 Heteromer
32-660
21×NAG; 1×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 4×NAG; 23×NAG;
Assess
vFP48.02 Fab in complex with BG505 DS-SOSIP Env trimer
8gas
 Heteromer
31-659
9×NAG; 9×NAG; 3×NAG; 36×NAG;
Assess
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.33104 (Wk26 time point)
7l8a
 Heteromer
32-660
30×NAG; 1×NAG; 2×NAG; 23×NAG;
Assess
BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment)
7mdt
 Heteromer
32-660
16×NAG; 1×NAG; 3×NAG; 31×NAG;
Assess
HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074
6udj
 Heteromer
Q6PIL8; Q8N355; S6B2B6; 		33-660
3×NAG; 18×NAG; 6×NAG; 6×NAG; 3×NAG; 9×NAG; 15×NAG;
Assess
The HIV-1 Envelope Glycoprotein Clone BG505 SOSIP.664 in Complex with Three Copies of the Bovine Br…
6pw6
 Heteromer
34-661
24×NAG; 6×NAG; 36×NAG;
Assess
BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-4 from animal Rh.33172 (Wk38 time poin…
7l8s
 Heteromer
32-659
3×NAG; 24×NAG; 1×NAG; 37×NAG;
Assess
BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 …
7kde
 Heteromer
33-660
1×NAG; 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×NAG; 8×NAG; 2×NAG; 3×NAG; 1×NAG; 34×NAG;
Assess
Crystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations …
5uty
 Heteromer
30-656
6×NAG; 3×NAG; 3×NAG; 27×NAG; 3×NAG; 24×NAG;
Assess
BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab
6vlr
 Heteromer
34-660
8×NAG; 4×NAG; 2×NAG; 3×NAG; 2×NAG; 24×NAG;
Assess
BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F
6vn0
 Heteromer
32-658
6×NAG; 27×NAG; 21×NAG;
Assess
BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time poin…
7l8f
 Heteromer
32-658
3×NAG; 11×NAG; 49×NAG;
Assess
Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11B fragment …
6x98
 Heteromer
34-660
9×NAG; 3×NAG; 36×NAG;
Assess
BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-3 from animal Rh.33172 (Wk38 time poin…
7l8g
 Heteromer
32-658
3×NAG; 22×NAG; 39×NAG;
Assess
BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20J
6vo1
 Heteromer
32-658
21×NAG; 3×NAG; 3×NAG; 18×NAG;
Assess
Asymmetrically open conformational state (Class II) of HIV-1 Env trimer BG505 SOSIP.664 in complex …
6u0n
 Heteromer
P01730; 		32-657
2×NAG; 3×NAG; 24×NAG;
Assess
Cryo-EM structure of CD4bs antibody Ab1303 in complex with HIV-1 Env trimer BG505 SOSIP.664
7tfn
 Heteromer
32-657
1×NAG; 4×NAG; 6×NAG; 5×NAG; 8×NAG; 1×MAN;
Assess
BG505 SOSIP.664 with 2G12 Fab2
6ozc
 Heteromer
34-658
3×NAG; 6×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; 21×NAG;
Assess
HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylate…
6x9u
 Heteromer
34-658
12×NAG; 3×NAG; 51×NAG;
Assess
Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab
7lok
 Heteromer
32-656
1×NAG; 1×NAG; 1×NAG; 8×NAG;
Assess
HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab
6x9s
 Heteromer
34-658
12×NAG; 3×NAG; 51×NAG;
Assess
HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endog…
6x9v
 Heteromer
34-658
12×NAG; 3×NAG; 51×NAG;
Assess
Asymmetrically open conformational state (Class I) of HIV-1 Env trimer BG505 SOSIP.664 in complex w…
6u0l
 Heteromer
P01730; 		32-656
4×NAG; 2×NAG; 1×NAG; 21×NAG;
Assess
HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab
6x9t
 Heteromer
34-658
12×NAG; 3×NAG; 51×NAG;
Assess
HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab
6x9r
 Heteromer
34-658
12×NAG; 3×NAG; 51×NAG;
Assess
Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab
7lo6
 Heteromer
32-656
7×NAG; 1×NAG; 1×NAG; 1×NAG; 27×NAG; 3×5VG;
Assess
Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 10A fragment …
6x96
 Heteromer
34-657
3×NAG; 9×NAG; 33×NAG;
Assess
Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11A fragment …
6x97
 Heteromer
33-656
12×NAG; 3×NAG; 27×NAG;
Assess
Structure of HIV-1 BG505 SOSIP-HT2 in complex with two CD4 molecules (class I)
8fyj
 Heteromer
P01730; Q2N0S5; 		33-656
4×NAG; 4×NAG; 1×NAG; 7×NAG;
Assess
Cryo-EM structure of BG505 SOSIP HIV-1 Env trimer in complex with CD4 receptor (D1D2) and broadly n…
7txd
 Heteromer
P01730; 		32-654
2×NAG; 8×NAG; 11×NAG; 1×NAG; 30×NAG;
Assess
HIV Env BG505 NFL TD+ in complex with antibody E70 fragment antigen binding
6p62
 Heteromer
35-654
12×NAG; 3×NAG; 3×NAG; 27×NAG;
Assess
Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with an early putative precu…
5cez
 Heteromer
31-504
1×NAG; 6×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 3×NAG; 1×MAN;
Assess
XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex …
6ch7
 Heteromer
Q2N0S5; 		31-504
3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG;
Assess
Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with …
6ch8
 Heteromer
Q2N0S5; 		31-504
6×NAG; 12×NAG; 9×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 12×NAG;
Assess
Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with …
6chb
 Heteromer
Q2N0S5; 		30-502
Assess
Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP
8fr6
 Heteromer
Q2N0S7; 		30-502
9×NAG; 6×NAG; 24×NAG; 3×NAG; 21×NAG;
Assess
HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1
6did
 Heteromer
A0A1Y1B8B1; P01840; Q2N0S7; 		31-503
3×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG;
Assess
Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibo…
7ll2
 Heteromer
Q2N0S7; 		30-502
21×NAG; 3×NAG; 6×NAG; 3×NAG; 12×NAG;
Assess
Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP
8g4t
 Heteromer
Q2N0S7; 		30-502
3×NAG; 36×NAG; 3×NAG; 3×NAG; 15×NAG;
Assess
Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP
8g4m
 Heteromer
Q2N0S7; 		30-502
4×NAG; 36×NAG; 1×NAG; 2×NAG; 12×NAG;
Assess
Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibo…
7ll1
 Heteromer
Q2N0S7; 		30-502
27×NAG; 3×NAG; 9×NAG;
Assess
Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antib…
6e5p
 Heteromer
Q2N0S9; 		30-502
9×MAN; 3×NAG; 6×NAG; 3×NAG;
Assess
Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elic…
6mpg
 Heteromer
Q2N0S7; 		30-502
21×NAG; 9×NAG; 3×NAG; 6×NAG; 3×NAG; 12×NAG;
Assess
Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicite…
6mph
 Heteromer
Q2N0S7; 		30-502
8×NAG; 12×NAG; 7×NAG; 12×NAG; 3×NAG; 9×NAG;
Assess
Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 En…
6cue
 Heteromer
Q2N0S7; 		30-502
21×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG;
Assess
Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 …
6n1w
 Heteromer
Q2N0S7; 		30-502
21×NAG; 9×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG;
Assess
Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env T…
6de7
 Heteromer
P01857; P04578; P0DOY2; 		31-502
6×NAG; 3×NAG; 3×NAG; 24×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4;
Assess
Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074
8ttw
 Heteromer
Q2N0S5; 		31-502
33×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; 3×83J;
Assess
VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure
6v8z
 Heteromer
P0DOX5; Q2N0S7; Q6N089; Q6P5S8; Q8N5F4; 		31-502
27×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG;
Assess
HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody F…
6mar
 Heteromer
Q2N0S7; 		31-502
22×NAG; 1×NAG; 2×NAG; 1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 22×NAG;
Assess
Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment
6mn7
 Heteromer
Q2N0S7; 		32-502
18×NAG; 21×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG;
Assess
VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure
6v8x
 Heteromer
Q2N0S9; Q6N095; Q6PIL8; 		32-502
3×NAG; 21×NAG; 12×NAG; 15×NAG;
Assess
Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG5…
6utk
 Heteromer
Q2N0S9; 		32-501
15×NAG; 3×NAG; 12×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 24×NAG;
Assess
Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefus…
6v6w
 Heteromer
Q2N0S9; 		32-501
3×NAG; 3×NAG; 3×NAG; 36×NAG;
Assess
BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding
6dfg
 Heteromer
Q2N0S8; 		32-500
3×NAG; 15×NAG; 6×NAG; 3×NAG; 3×NAG; 18×NAG;
Assess
BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding
6dfh
 Heteromer
Q2N0S5; 		32-499
18×NAG; 3×NAG; 3×NAG; 18×NAG;
Assess
Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizin…
4nco
 Heteromer
43-490
12×NAG; 3×NAG; 3×MAN; 30×NAG;
Assess
Cryo-EM structure of the BG505 SOSIP.664 HIV-1 Env trimer with 3 PGV04 Fabs
3j5m
 Heteromer
43-489
Assess
cryoEM reconstruction of the HIV gp140 in complex with the extracellular domains of CD4 and the adn…
7t0o
 Heteromer
P01730; 		46-487
Assess
Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs
8e1p
 Heteromer
515-661
4×NAG; 9×NAG; 1×NAG; 1×NAG; 1×NAG; 1×MAN; 30×NAG;
Assess
Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573
7tfo
 Heteromer
A0A6H1VH54; 		511-657
1×NAG; 3×NAG; 1×NAG; 5×NAG;
Assess
Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664
7l6o
 Heteromer
A0A1W6IPB2; 		516-661
27×NAG; 9×NAG; 3×NAG; 18×NAG;
Assess
ApexGT5 in complex with GT5-d42.16 and RM20A3 Fabs
7t9b
 Heteromer
517-659
10×NAG; 3×NAG; 2×NAG; 1×NAG; 3×NAG; 3×NAG; 41×NAG;
Assess
Crystal Structure of Ligand-Free BG505 SOSIP.664 HIV-1 Env Trimer
4zmj
homo-6-mer33-661
3×NAG; 6×NAG; 45×NAG;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7n6u.1.Ahomo-3-mer0.5930-660
1×NAG;76.22
Assess